EGFR TKI combination with immunotherapy in non-small cell lung cancer

MJ Ahn, JM Sun, SH Lee, JS Ahn… - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has
significantly improved clinical outcomes compared with chemotherapy in non-small cell lung …
被引用次数：192 相关文章

[引用][C] EGFR TKI combination with immunotherapy in non-small cell lung cancer

MJ Ahn, JM Sun, SH Lee, JS Ahn, K Park - Expert Opinion on Drug …, 2017 - cir.nii.ac.jp
EGFR TKI combination with immunotherapy in non-small cell lung cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

EGFR TKI combination with immunotherapy in non-small cell lung cancer.

MJ Ahn, JM Sun, SH Lee, JS Ahn… - Expert Opinion on Drug …, 2017 - europepmc.org
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has significantly
improved clinical outcomes compared with chemotherapy in non-small cell lung cancer …

EGFR TKI combination with immunotherapy in non-small cell lung cancer

MJ Ahn, JM Sun, SH Lee, JS Ahn… - EXPERT OPINION ON …, 2017 - scholarworks.bwise.kr
Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has
significantly improved clinical outcomes compared with chemotherapy in non-small cell lung …

EGFR TKI combination with immunotherapy in non-small cell lung cancer

MJ Ahn, JM Sun, SH Lee, JS Ahn… - Expert opinion on drug …, 2017 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has significantly
improved clinical outcomes compared with chemotherapy in non-small cell lung cancer …

EGFR TKI combination with immunotherapy in non-small cell lung cancer

MJ Ahn, JM Sun, SH Lee… - Expert Opinion on …, 2017 - mdanderson.elsevierpure.com
Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has
significantly improved clinical outcomes compared with chemotherapy in non-small cell lung …